Skip to content

Prevention of Progression Knee Osteoarthritis

Prevention of Progression of Knee Osteoarthritis Using Various Treatment Regimens: A Randomized Clinical Trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
PACTR
Registry ID
PACTR201804003315170
Enrollment
250
Registered
2018-04-08
Start date
2011-03-01
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Musculoskeletal Diseases Osteoarthritis

Interventions

group 1
group 2
group 3

Sponsors

Faculty of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: -symptomatic and radiographic diagnostic criteria of early knee OA -age 45-55 years -Body mass index less than 30.

Exclusion criteria

Exclusion criteria: -Patients with causes of secondary KOA (e.g. rheumatoid, gouty, traumatic soft tissues and bony injuries, mechanical malalignment with varus > 10 degrees and valgus > 15 after obtaining full limb radiograghs, etc.) -a history of knee surgery -intra-articular injection -use of antiresorptive drugs within the 12 months preceding enrollment.

Design outcomes

Primary

MeasureTime frame
The outcome instrument for evaluation of treatment regimen efficacy on symptoms of OA was the Western Ontario and McMaster Universities (WOMAC) OA index ;The visual analog scale (VAS) ;Radiographical evaluation included 1.5 T MRI ;measurement of urinary levels of the N-terminal crosslinking telopeptide of type I collagen ;measurement of urinary levels of C-terminal crosslinking telopeptide of type II collagen

Secondary

MeasureTime frame
Return to level of activity that was prior to symptoms of disease (Osteoarthritis).

Countries

Egypt

Contacts

Public ContactElsayed Morsi

Professor of Orthopedic Surgery, Faculty of Medicine, Menoufia University

dr.elsayedmorsi@gmail.com00201227469041

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Aug 9, 2026